PTAB challenges

Based on your request, here is an analysis of the AIA trial proceedings for US patent 9,900,569.

Proceedings overview

One Inter Partes Review (IPR) has been filed against US patent 9,900,569, and it resulted in a discretionary denial of institution. This means the patent's claims have never been reviewed on the merits by the Patent Trial and Appeal Board (PTAB). For a defendant, this indicates the patent has not been "hardened" by surviving a PTAB trial, but it also shows the patent owner has successfully used parallel litigation to avoid a PTAB validity challenge.

IPR2025-00942 — Coretronic Corporation v. Maxell, Ltd.

• Type: Inter Partes Review
• Filed: 2025-05-14
• Status: Discretionary Denial. This means the PTAB exercised its discretion to decline instituting a trial, not based on the merits of the unpatentability arguments, but for procedural reasons related to a co-pending district court case.
• Judge panel: I do not have access to live USPTO data to confirm the specific Administrative Patent Judges on the panel for this decision. This information would be available in the institution decision document itself.
• Petition grounds: I do not have access to the petition document. Typically, an IPR petition would challenge specific claims (e.g., claims 1-10) as being either anticipated (§ 102) or obvious (§ 103) in view of specific prior art references (e.g., previously issued patents or printed publications).
• Institution decision: The proceeding was terminated with a discretionary denial on 2025-10-27. This type of denial, often based on the precedent set in Apple Inc. v. Fintiv, Inc., IPR2020-00019, Paper 11 (Mar. 20, 2020), occurs when there is a parallel district court litigation involving the same patent. The Board likely determined that the court case was at an advanced stage, and hearing the IPR would be an inefficient use of resources given the overlap in issues.
• Final Written Decision: None issued, as the trial was never instituted.
• Settlement / termination: The proceeding was terminated by the Board's denial to institute; no settlement was necessary to end the IPR itself.
• Appeal: Not applicable. Decisions to deny institution of an IPR are not appealable to the Federal Circuit.
• Defensive value: The underlying invalidity arguments raised by the petitioner were never tested by the PTAB. However, this proceeding serves as a clear warning that the patent owner, Maxell, will likely leverage any co-pending litigation to argue for a discretionary denial against future IPRs. A new challenger must be prepared to aggressively counter arguments based on the Fintiv factors.

Strategic summary

The patent validity analysis is shaped by the single, unsuccessful attempt to challenge the patent at the PTAB.

• Claim Status: All claims of US patent 9,900,569 are currently UNTESTED in any AIA trial proceeding. No claims have been canceled, and no claims have been sustained by the PTAB in a Final Written Decision.

• Estoppel landscape: Because the IPR did not result in a Final Written Decision, the petitioner (Coretronic Corporation) is not subject to IPR estoppel under 35 U.S.C. § 315(e). A new defendant facing an assertion of this patent is completely free to file its own IPR and raise any prior art grounds it deems appropriate, without any estoppel from this prior proceeding.

• Pattern signals: The discretionary denial strongly suggests the existence of parallel district court litigation. Patent owners who successfully use a Fintiv-based defense often do so by filing lawsuits in districts known for moving cases quickly to trial, thereby creating pressure on the PTAB to deny institution. This signals an aggressive defensive strategy by the patent owner focused on keeping validity challenges confined to the district court forum.

  Note on potential data contradiction: The information provided in the "Litigation summary" section states there was no known litigation as of April 26, 2026. However, the discretionary denial in IPR2025-00942, issued in late 2025, is almost certainly predicated on a parallel district court case filed before that date. This suggests the prior litigation search may be incomplete or outdated, as the PTAB record provides strong evidence that this patent has been asserted in court.

Recommended next steps

• Investigate the parallel litigation: A defendant's first step should be to identify and analyze the district court case that triggered the discretionary denial in IPR2025-00942. The case name would likely be Maxell, Ltd. v. Coretronic Corporation. The invalidity contentions, expert reports, and ultimate court ruling (if any) on validity in that case are critical intelligence.
• Plan for a Fintiv challenge: If you are sued and consider filing a new IPR, you must have a strategy to overcome the same discretionary denial arguments. This may involve:
  1. Filing the IPR as quickly as possible after being sued, before the district court case has advanced significantly.
  2. Arguing that the prior art or invalidity theories in your IPR are materially different from those being litigated in court.
  3. Considering a stipulation to not pursue the same invalidity grounds in district court if the PTAB institutes your IPR, which can help overcome a Fintiv denial.
• No claims have been invalidated: Since the only PTAB challenge was denied before a trial on the merits could begin, a defendant cannot simply point to a PTAB decision to dispose of infringement claims. The patent must be treated as having survived its only PTAB encounter, albeit on procedural grounds. All claims remain presumptively valid.